Skip to main content
Earnings Labs
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT)

NASDAQ·Healthcare·Biotechnology

$20.72

+3.99%

Mkt Cap $512.42M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (1 analysts)

$10.00

Range $10.00$10.00

Implied Upside

-51.7%

Consensus $10.00 vs current $20.72